🚨 New Study Shows Paxlovid Could Cause Deadly Blood Clots, Dr. Houman Hemmati Reacts

"Paxlovid didn't have these lengthy Phase 1, 2, and 3 trials. It was rushed to market under an Emergency Use Authorization, never an approval. And as a result they've skipped a lot of these studies so what we're learning about that drug and its safety is largely based on post-marketing data - people who are actually getting it in real-world usage and then we find out through them."